Company page

Neogenomics, Inc.

Neogenomics, Inc. is a publicly traded company listed under the ticker NEO, operating in the American market. The company has a market capitalization of approximately $1.81 billion. Neogenomics specializes in cancer genetics and provides a range of diagnostic services to healthcare providers.